382
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma

, , , , , , , , , , , , , , , , , , , & show all
Pages 3378-3386 | Received 19 May 2020, Accepted 12 Aug 2020, Published online: 27 Aug 2020

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.